Organised screening Number (%) | Opportunistic screening Number (%) | ORa | CI95%a | P-value | |||
---|---|---|---|---|---|---|---|
Breast Surgery | |||||||
Tumorectomy | 279 | (85.1) | 142 | (78.5) | 1 | [0.98; 2.50] | 0.060 |
Mastectomy | 49 | (14.9) | 39 | (21.5) | 1.6 | ||
Lymph-adenectomy | |||||||
Yes | 85 | (25.8) | 45 | (24.6) | 1 | [0.70; 1.62] | 0.771 |
No | 245 | (74.2) | 138 | (75.4) | 1.0 | ||
Radiation therapy | |||||||
Yes | 295 | (89.4) | 146 | (79.8) | 1 | [1.29; 3.53] | 0.003 |
No | 35 | (10.6) | 37 | (20.2) | 2.1 | ||
Hormone therapy c | |||||||
Yes | 278 | (84.2) | 147 | (80.3) | 1 | [0.82; 2.09] | 0.261 |
No | 52 | (15.8) | 36 | (19.7) | 1.3 | ||
Chemotherapy | |||||||
Yes | 124 | (37.6) | 59 | (32.2) | 1 | [0.86; 1.85] | 0.227 |
No | 206 | (62.4) | 124 | (67.8) | 1.3 | ||
Trastuzumabc | |||||||
Yes | 26 | (7.9) | 17 | (9.3) | 1 | [0.44; 1.58] | 0.581 |
No | 304 | (92.1) | 166 | (90.7) | 0.8 | ||
Time to treatment [days] | |||||||
Mean (SDa) | 12.9 | (8.0) | 12.0 | (8.2) | 0.214b |